IFN-γ-induced PD-L1 expression has been reported in several cancer cells [14,42,43], and this mechanism is mostly mediated by activating IFNGR1/2-Janus kinase (JAK)/STAT1 pathways [43,44,45,46]. The gene discussed is STAT1; the disease is cancer.